US News

EU advises against AstraZeneca shot in people with rare blood condition

Published by
Reuters

(Reuters) – Europe’s drug regulator on Friday advised against using AstraZeneca’s COVID-19 vaccine in people with a history of a rare bleeding condition and said it was looking into heart inflammation cases after inoculation with all coronavirus shots. The European Medicines Agency’s (EMA) safety committee in its evaluation said that capillary leak syndrome must be added as a new side effect to labelling on AstraZeneca’s vaccine. It is a condition in which blood leaks from the smallest of vessels into muscles and body cavities and is characterised by swelling and a drop in blood pressure. The …

Read More

Facebook Comments

Check Also

Ukraine’s foreign minister warns EU risks paying war costs twice

Published by DPA The European Union must stop ...

Archives